TY - JOUR
T1 - Brain tumors in the very young child
T2 - Postoperative chemotherapy in combined‐modality treatment
AU - Horowitz, Marc E.
AU - Mulhern, Raymond K.
AU - Kun, Larry E.
AU - Kovnar, Edward
AU - Sanford, Robert A.
AU - Simmons, James
AU - Hayes, F. Ann
AU - Jenkins, Jesse J.
PY - 1988/2/1
Y1 - 1988/2/1
N2 - Twelve consecutively diagnosed children with brain tumors, ages 7 to 27 months, were treated by a combined‐modality approach featuring aggressive surgical resection followed by chemotherapy and delayed irradiation. Patients received multiple clinical neurologic examinations and psychological evaluations, as well as diagnostic imaging studies, to monitor the efficacy of chemotherapy and toxic effects of therapy. Six of the eight children with residual tumor evident postoperatively on computed tomography scans had objective responses to chemotherapy. The efficacy of chemotherapy was further demonstrated by the lack of disease progression for 7 months or longer in eight children, seven of whom remain free of tumor 19 to 57 months (median, 28 months) from the date of diagnosis. The neurologic status of ten patients improved during treatment. Developmental progress was normal in two, low average in three, and frankly deficient in four of ten children formally evaluated. These results indicate that postoperative chemotherapy, added to a regimen of surgical resection and delayed irradiation, prolong survival with only minimal short term neurotoxicity in the majority of very young children with malignant brain tumors.
AB - Twelve consecutively diagnosed children with brain tumors, ages 7 to 27 months, were treated by a combined‐modality approach featuring aggressive surgical resection followed by chemotherapy and delayed irradiation. Patients received multiple clinical neurologic examinations and psychological evaluations, as well as diagnostic imaging studies, to monitor the efficacy of chemotherapy and toxic effects of therapy. Six of the eight children with residual tumor evident postoperatively on computed tomography scans had objective responses to chemotherapy. The efficacy of chemotherapy was further demonstrated by the lack of disease progression for 7 months or longer in eight children, seven of whom remain free of tumor 19 to 57 months (median, 28 months) from the date of diagnosis. The neurologic status of ten patients improved during treatment. Developmental progress was normal in two, low average in three, and frankly deficient in four of ten children formally evaluated. These results indicate that postoperative chemotherapy, added to a regimen of surgical resection and delayed irradiation, prolong survival with only minimal short term neurotoxicity in the majority of very young children with malignant brain tumors.
UR - http://www.scopus.com/inward/record.url?scp=0023849599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023849599&partnerID=8YFLogxK
U2 - 10.1002/1097-0142(19880201)61:3<428::AID-CNCR2820610304>3.0.CO;2-A
DO - 10.1002/1097-0142(19880201)61:3<428::AID-CNCR2820610304>3.0.CO;2-A
M3 - Article
C2 - 3338013
AN - SCOPUS:0023849599
SN - 0008-543X
VL - 61
SP - 428
EP - 434
JO - Cancer
JF - Cancer
IS - 3
ER -